ACTRN12624000627550
Not yet recruiting
未知
Biomarkers for Barrett’s Oesophagus and neoplastic progression: Finding the proteomic spitting image in adult patients
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Royal Brisbane & Women's Hospital
- Enrollment
- 250
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Referral for investigation of reflux symptoms or other suspected gastrointestinal disease, as well as patients with established Barrett’s oesophagus and/or suspected or established oesophageal adenocarcinoma
- •Age between 18 and 100 years old
- •Willingness to participate for the duration of the trial period
- •Provision of written Informed Consent for participation in this study
Exclusion Criteria
- •Patients medically unsuitable for further testing or oesophageal screening, as determined by the treating clinician.
- •High risk of poor compliance to participate with study requirements or follow\-up as assessed by the investigator
- •Current illness that will interfere with the collection of saliva, gastric secretions and/or blood samples
- •Previous invasive malignancy within 5 years of current diagnosis with the exception of skin cancer other than melanoma.
- •Previous cancer treatment in the last 5 years.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Detection of early neoplasia in Barrett’ esophagus: Do not focus on Barrett’s surveillance – diagnosis is at the indexendoscopy in SSBE with biopsiesC15.5Lower third of oesophagusDRKS00004168HSKInnere Medizin 2143
Completed
Not Applicable
Diagnosis of early Barrett’s neoplasia and esophageal squamous cell neoplasia by electrical bio-impedance spectroscopy in human tissueC15.9K22.7Oesophagus, unspecifiedBarrett oesophagusDRKS00003358Dr. Horst-Schmidt-Klinik WiesbadenII. Medizinische Klinik23
Completed
Not Applicable
Early detection of Barrett's esophagus and esophageal cancer: accuracy and acceptability of a novel screening strategy in primary care.Barrett's esophagusesophageal adenocarcinomaEsophageal cancer10017990NL-OMON49567Radboud Universitair Medisch Centrum450
Completed
Not Applicable
BETERNet Notch Signaling and Novel Biomarkers for Barretts EsophagusBarrett's EsophagusNCT01484925Abramson Cancer Center at Penn Medicine60
Active, not recruiting
Not Applicable
Developing new tests to detect oesophageal dysplasia in patients using historic capsule sponge dataOesophageal dysplasiaDigestive SystemISRCTN15940781Cyted Ltd150